fludara
Changing product quantity in your shopping cart
When you have selected your item you can see your shopping cart items, quantity and total. You can change the quantity by entering the number of quantity you want. Then press 'Update' to change the quantity required.
|
Fludara (other)
US Brand: Fludara
Manufacturer: Other
|
|
FLUDARABINE: it is a cytoioxic cherno-thera-peutic agent.
Indications: Treatment of patients with B-cell chronic lymphocytic leukaemia (CLL) with sufficient bone marrow reserve and who have not responded to or whose disease has progressed during or after treatment with at least one alkylating agent containing regimen.
Dosage: Adults: 25mg/m2 body surface given daily for 5 consecutive days in every 28 days by IV
Contraindications: Hypersensitivity to this drug or its components. Renally impaired patients (creati-nine clearance 30ml/minute, and patients with decompensate hemolytic anemia Children).
Special Precautions: When use at high doses fludarabine is associated with blindness, coma and death. Preexisting skin cancer. Side effects: Myelo-suppression (neutropenia, throm-bocytopenia and anaemia], fever, chills, and infection. Oedema, malaise, fatigue, anorexia, nausea,
Drug Interactions: Pentostatin (deoxycoformycin): use of fludarabine in combination with pentostatin is not recommended because of a very high incidence of fatal pulmonary toxicity. Adenosine uptake inhibitors : The therapeutic efficacy of fiudarabine may be reduced by dipyridamole and other adenosine